CompuMed, Inc. (OTCBB:CMPD) (www.compumed.net) unveiled its landmark CardioGramKids™ program at the 2009 Masters of Pediatrics Conference in Miami, sponsored by the highly respected University of Miami Miller School of Medicine, Department of Pediatrics. CardioGramKids is a national physician outreach program designed to provide electrocardiogram (ECG) screening services to children and adolescents prior to prescribing or taking psychotropic medications, including stimulants. Miller is the first to partner with CompuMed on the project.

According to Eugene R. Hershorin, M.D., Chief, Division of General Pediatrics, Director - Masters of Pediatrics, "This year's 18th annual Masters of Pediatrics Conference was again a rousing success and called by current and past pediatric leaders ‘the best academic pediatric conference in America.’” Dr. Hershorin added that the conference featured some of the most well known pediatric experts in America including Drs. Basil Zitelli, Joseph Zenel, Barbara Howard, Michael Pichichero, Steven Lipshultz and many others. It was attended by more than 600 pediatricians and other child health providers from more than 40 states and five foreign countries. Following the three-day general pediatric conference were four specialty conferences on Pediatric Cardiology, Development and Behavior, Infectious Diseases and Dermatology.

“CompuMed was delighted to serve as a benefactor for this important Pediatric Masters Conference,” said Maurizio Vecchione, CompuMed’s CEO. “We showcased our CardioGramKids program and provided information to attendees about the risk of developing or exacerbating potentially serious or life threatening cardiac conditions without prior ECG screenings.”

CompuMed remotely interprets ECGs on pediatric patients in this first-of-its-kind program to detect heart abnormalities prior to psychotropic and stimulant drug therapy. Medical journals have long reported concerns regarding the appropriateness of such therapy without screening at risk patients. Acting on reports of sudden death in children and adolescents treated with stimulants and other psychotropic medications for conditions such as attention deficit hyperactivity disorder, commonly referred to as ADHD, CompuMed’s program dovetailed with the conference’s mission, which is to provide pediatricians with the latest in contemporary and future pediatric knowledge.

According to Tommy Schechtman, MD, MS, FAAP, President, Pediatric Partners of Palm Beach Gardens, FL, who attended the conference, “This [CardioGramKids] will be a marked improvement in providing better care.